Hepatitis C Prevalence in Hemodialysis Patients and the Results of New Antiviral Therapy

ÇELİK N., ÇELİK O., SEVİNÇ C., ÜNAL O.

TURKISH JOURNAL OF NEPHROLOGY, cilt.28, sa.2, ss.103-108, 2019 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5152/turkjnephrol.2019.3311
  • Dergi Adı: TURKISH JOURNAL OF NEPHROLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.103-108
  • Atatürk Üniversitesi Adresli: Evet

Özet

Objective: Hepatitis C virus (HCV) is more common in patients undergoing dialysis compared to the normal population. The objective of this study was to investigate the incidence of hepatitis C in patients undergoing hemodialysis and to share the results of the antiviral drugs used in the treatment of our patients with HCV.